# An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

> **NCT00027365** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 84 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Combination Vaccine (NefTat and gp120W61D) Formulated with AS02A
- **BIOLOGICAL:** NefTat
- **DRUG:** AS02A Adjuvant
- **BIOLOGICAL:** gp120W61D

## Key facts

- **NCT ID:** NCT00027365
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 84 (—)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027365, "An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00027365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*